The Role of SGLT-2 Inhibitors in the Management of Heart Failure and Cardiovascular Outcomes
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
| dc.contributor.author | Aburaya, Ranee | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | |
| dc.contributor.opponent | Szentmiklósi, József | |
| dc.contributor.opponent | Halasi, Barbara | |
| dc.contributor.opponentdept | Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
| dc.contributor.opponentdept | Általános Orvostudományi Kar::Igazságügyi Orvostani Intézet | |
| dc.date.accessioned | 2026-11-16T10:57:28Z | |
| dc.date.created | 2026-01-21 | |
| dc.description.abstract | This thesis reviews the role of sodium-glucose co-transporter 2 (SGLT2) inhibitors in the treatment of heart failure. Although originally developed for type 2 diabetes, these drugs have shown significant cardiovascular and renal benefits independent of glucose control. The thesis examines their mechanisms of action, clinical effectiveness, safety profile, and evidence from major clinical trials demonstrating reduced heart failure hospitalizations and improved outcomes. Overall, SGLT2 inhibitors are highlighted as an important component of modern heart failure management with the potential to improve long-term patient outcomes | |
| dc.description.course | általános orvos | |
| dc.description.courselang | angol | |
| dc.description.degree | egységes, osztatlan | |
| dc.format.extent | 51 | |
| dc.identifier.uri | https://hdl.handle.net/2437/417309 | |
| dc.language.iso | en | |
| dc.rights.info | Hozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében. | |
| dc.subject | Heart Failure | |
| dc.subject | HFrEF | |
| dc.subject | HFmEF | |
| dc.subject | HFpEF | |
| dc.subject | Sodium-Glucose Cotransporter 2 Inhibitor | |
| dc.subject.dspace | Medicine::Pharmacology | |
| dc.subject.dspace | Medicine::Cardiology | |
| dc.title | The Role of SGLT-2 Inhibitors in the Management of Heart Failure and Cardiovascular Outcomes |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Betöltés ...
- Név:
- Aburaya Ranee_Thesis.pdf
- Méret:
- 2,32 MB
- Formátum:
- Adobe Portable Document Format